Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2025-12-30 @ 5:49 AM
Study NCT ID:
NCT06961006
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2025-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-05-29
Start Date Type:
ACTUAL
Primary Completion Date:
2028-07-22
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-09-05
Completion Date Type:
ESTIMATED
First Submit Date:
2025-04-29
First Submit QC Date:
None
Study First Post Date:
2025-05-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-03
Last Update Post Date:
2025-12-05
Last Update Post Date Type:
ESTIMATED